HOLON, Israel, July 18, 2018 /PRNewswire/ -- Compugen Ltd.
(NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a
leader in predictive target discovery, announced today that the
Company will release its second quarter 2018 financial results on
Wednesday, August 1, 2018 before the
U.S. financial markets open. Management will host a live webcast to
review the results and provide a corporate update at 8:30 AM ET (please note new time for conference
call).
To access the live conference call by telephone, please dial
1-888-668-9141 from the U.S., or +972-3-918-0609 internationally.
The call will also be available via live webcast through Compugen's
website, located at the following link. Following the live audio
webcast, a replay will be available on the Company's website.
About Compugen
Compugen is a clinical-stage,
therapeutic discovery and development company utilizing its broadly
applicable predictive discovery infrastructure to identify novel
drug targets and develop first-in-class therapeutics in the field
of cancer immunotherapy. The Company's therapeutic pipeline
consists of immuno-oncology programs against novel drug targets it
has discovered, including T cell immune checkpoints and myeloid
target programs. Compugen's business model is to selectively enter
into collaborations for its novel targets and related drug product
candidates at various stages of research and development. The
Company is headquartered in Israel
with R&D facilities in both Israel and South San
Francisco, CA. Compugen's ordinary shares are listed on
Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol
CGEN. For additional information, please visit Compugen's corporate
website at www.cgen.com.
Company contact:
Elana
Holzman
Director, Investor Relations and Corporate Communications
Compugen Ltd.
Email: elanah@cgen.com
Tel: +972 (3) 765-8124
Investor Relations contact:
Burns McClellan, Inc.
Jill Steier
Email: jsteier@burnsmc.com
Tel: 212-213-0006
View original
content:http://www.prnewswire.com/news-releases/compugen-second-quarter-2018-conference-call-scheduled-for-wednesday-august-1-2018-at-830-am-et-300682807.html
SOURCE Compugen Ltd.